Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

The Conference Board of Canada and The Globe and Mail are partnering to explore the relationship between career success and cannabis use. Employers and employees (both recreational and medical cannabis users, as well as non-cannabis users) are invited to participate in this study. (Employees interested in taking the survey can click on this link.; Employers interested in taking the survey can click on this link.) The data from these surveys will be aggregated and used to conduct analysis and create a report that will be presented Oct. 15, 2019 at a conference at The Globe and Mail Centre in Toronto.

Getty Images/iStockphoto

Canadian society has come a long way since cannabis prohibition began in the 1920s – when the plant was listed under the Narcotics Drug Act Amendment Bill. Some 80 years later, Health Canada allowed access to cannabis for medical purposes following an Ontario Court of Appeal decision.

While cannabis has been used by people for thousands of years, we still know relatively little about how it works as a medicine. Medical cannabis use in Canada increased from 23,930 registered users in 2015 to over 330,000 in 2018, an 14-times increase in just three years.

Story continues below advertisement

The more widespread use of medical cannabis is causing challenges for some employers as they try to balance their employees’ health with maintaining a safe and productive workplace. Employers are mainly concerned about the potential risks of employees being impaired on the job due to cannabis.

Under human rights legislation, employers need to accommodate any employee with medical authorization to use cannabis, as long as it does not cause undue hardship for the workplace.

Employers with workers approved for medical cannabis accommodations should ensure these employees understand the organizations’ substance use policies – in particular, impairment and fit-for-duty policies. For their part, employees who receive medical accommodations must be sure they don’t breach these agreed-upon terms.

In spite of the growing number of people using cannabis as a medical treatment, there are still relatively few employers covering it under their benefits plans.


Cannabis is considered an effective treatment for many medical conditions. These include Alzheimer’s, nausea from chemotherapy, epilepsy, seizures, glaucoma, multiple sclerosis, post-traumatic stress disorder, chronic pain, anxiety and depression.

Researchers are examining different cannabis strains to see how effective they are for a variety of medical conditions. Medical cannabis, part of a class of medicines called cannabinoid-based medicines, is currently administered as oils, capsules or tablets, and by vaporizing or smoking in dried form. Premixed topical creams and edibles are not currently legal for sale in Canada, though patients may prepare cannabis these ways themselves.

Story continues below advertisement

Cannabinoids are a type of compound that are part of a natural chemical communication system in our bodies. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most common cannabinoids. While THC is known for its psychoactive effects, CBD is best understood for its potential therapeutic uses – it doesn’t have the psychoactive effect that THC does. This is a key factor, especially for those cautious about workplace impairment. Some strains of medical cannabis are high in CBD and low in THC, meaning the psychoactive effect is significantly reduced.

One challenge with medical cannabis is that there is a knowledge gap for the average person (or physician) when it comes to assessing medical conditions and symptoms and selecting the best cannabis strain and dosing strength or method.


Even though cannabis has been approved as a medical treatment, there are still stereotypes and stigma associated with the drug. This may be a barrier for some employees who are authorized by a physician to use medical cannabis as a treatment for medical conditions.

Cannabis Standard is an online tool for people suffering from conditions that may benefit from medical cannabis, designed to help them access the most current information on its effectiveness. It allows people to take ownership and understand the treatment options available. This tool is not intended as a substitute for medical advice, only to help people work with their doctor to find the best treatment for their condition.


Story continues below advertisement

Employees who have consulted with their physicians and determined that medical cannabis might be helpful for their condition must decide whether they want to try the drug as a treatment. The next step is to determine whether their job is eligible for a medical cannabis accommodation to allow them to use the drug before or during work. Employees working in safety-sensitive roles may face more barriers than those in non-safety-sensitive roles.

Most organizations have updated their substance use policies to account for medical cannabis accommodations. In organizations where this has not been done, employees are advised to talk with their direct manager or human resources department to find out if their role is eligible.

In addition, employees who are eligible for an accommodation should find out if their current benefits plan covers medical cannabis. Some employers are taking proactive steps toward determining if they should cover medical cannabis in their health plans by using confidential employee health surveys to determine what percentage of employees are using medical cannabis.

Given the expected shift in mindset when it comes to medical cannabis, both employers and employees –especially those with chronic diseases that may benefit from its use – need to stay current with the growing body of research on medical cannabis.

Bill Howatt is the chief of research for workforce productivity at The Conference Board of Canada.

Helen Stevenson is the CEO and founder of Reformulary Group

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the authors of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies